Clarus Therapeutics

Clarus picks up FDA OK for oral testosterone drug
BioPharma Dive
Sat, 03/30/19 - 12:05 am
Clarus Therapeutics
testosterone
FDA
Jatenzo
The FDA still hates low T drugs — experts bat back a pair of contenders
Endpoints
Thu, 01/11/18 - 09:46 am
FDA
testosterone
Lipocine
Tlando
Clarus Therapeutics
Jatenzo
FDA advisers shoot down Clarus' pitch for a new low-T drug
Fierce Biotech
Fri, 09/19/14 - 08:58 am
FDA
Clarus Therapeutics
advisory panels
Rextoro
testosterone
Possible Heart Risk With Testosterone Spurs Debate on Use
Bloomberg
Tue, 09/16/14 - 09:24 am
testosterone
Eli Lilly
Auxilium
Rextoro
Clarus Therapeutics
Clarus Therapeutics Files To Sell Up To $86.3M In Shares In IPO
WSJ
Sat, 11/20/10 - 12:47 pm
Clarus Therapeutics
OriTex
testosterone